Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation

2minutemedicine.com

There was a total of 52 240 new starts of dabigatran and 66 651 new starts of rivaroxaban during the study period. Rivaroxaban was associated with a non-significant decrease in thromboembolic stroke. There was also a non-significant increase in mortality associated with rivaroxaban.

Read More